179 related articles for article (PubMed ID: 12759464)
21. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.
Ferrera F; Hahn BH; Rizzi M; Anderson M; Fitzgerald J; Millo E; Indiveri F; Shi FD; Filaci G; La Cava A
Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718
[TBL] [Abstract][Full Text] [Related]
22. Rapamycin attenuates the severity of established nephritis in lupus-prone NZB/W F1 mice.
Lui SL; Tsang R; Chan KW; Zhang F; Tam S; Yung S; Chan TM
Nephrol Dial Transplant; 2008 Sep; 23(9):2768-76. PubMed ID: 18445640
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
24. Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice.
Haas KM; Watanabe R; Matsushita T; Nakashima H; Ishiura N; Okochi H; Fujimoto M; Tedder TF
J Immunol; 2010 May; 184(9):4789-800. PubMed ID: 20368280
[TBL] [Abstract][Full Text] [Related]
25. Effect of E6060 [4-{5-[7-fluoro-4-(trifluoromethyl)benzo[b]furan-2-yl]-1H-2-pyrrolyl}benzoic acid], a novel subtype-selective retinoid, on lupus-like nephritis in female (NZBxNZW)F1 mice.
Yamauchi T; Ishibashi A; Shikata K; Tokuhara N; Seino K; Kobayashi S; Nagai M
J Pharmacol Exp Ther; 2005 Mar; 312(3):938-44. PubMed ID: 15615868
[TBL] [Abstract][Full Text] [Related]
26. Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis.
Ozmen L; Roman D; Fountoulakis M; Schmid G; Ryffel B; Garotta G
Eur J Immunol; 1995 Jan; 25(1):6-12. PubMed ID: 7843255
[TBL] [Abstract][Full Text] [Related]
27. Immunization with pentraxin 3 (PTX3) leads to anti-PTX3 antibody production and delayed lupus-like nephritis in NZB/NZW F1 mice.
Gatto M; Ghirardello A; Luisetto R; Bassi N; Fedrigo M; Valente M; Valentino S; Del Prete D; Punzi L; Doria A
J Autoimmun; 2016 Nov; 74():208-216. PubMed ID: 27405845
[TBL] [Abstract][Full Text] [Related]
28. Prevention of lupus nephritis development in NZB/NZW mice by selective blockade of CD28.
Laurent L; Le Fur A; Bloas RL; NĂ©el M; Mary C; Moreau A; Poirier N; Vanhove B; Fakhouri F
Eur J Immunol; 2017 Aug; 47(8):1368-1376. PubMed ID: 28631301
[TBL] [Abstract][Full Text] [Related]
29. Effects of administration of monoclonal antibodies (anti-CD4 or anti-CD8) on the development of autoimmune diseases in (NZW x BXSB)F1 mice.
Adachi Y; Inaba M; Sugihara A; Koshiji M; Sugiura K; Amoh Y; Mori S; Kamiya T; Genba H; Ikehara S
Immunobiology; 1998 Feb; 198(4):451-64. PubMed ID: 9562869
[TBL] [Abstract][Full Text] [Related]
30. Terminal deoxynucleotidyl transferase deficiency reduces the incidence of autoimmune nephritis in (New Zealand Black x New Zealand White)F1 mice.
Conde C; Weller S; Gilfillan S; Marcellin L; Martin T; Pasquali JL
J Immunol; 1998 Dec; 161(12):7023-30. PubMed ID: 9862739
[TBL] [Abstract][Full Text] [Related]
31. Anti-programmed cell death 1 antibody reduces CD4+PD-1+ T cells and relieves the lupus-like nephritis of NZB/W F1 mice.
Kasagi S; Kawano S; Okazaki T; Honjo T; Morinobu A; Hatachi S; Shimatani K; Tanaka Y; Minato N; Kumagai S
J Immunol; 2010 Mar; 184(5):2337-47. PubMed ID: 20139271
[TBL] [Abstract][Full Text] [Related]
32. Delayed lupus onset in (NZB x NZW)F1 mice expressing a human C-reactive protein transgene.
Szalai AJ; Weaver CT; McCrory MA; van Ginkel FW; Reiman RM; Kearney JF; Marion TN; Volanakis JE
Arthritis Rheum; 2003 Jun; 48(6):1602-11. PubMed ID: 12794828
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.
Ryffel B; Car BD; Gunn H; Roman D; Hiestand P; Mihatsch MJ
Am J Pathol; 1994 May; 144(5):927-37. PubMed ID: 8178944
[TBL] [Abstract][Full Text] [Related]
34. Mycophenolate mofetil suppresses autoimmunity and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus.
McMurray RW; Elbourne KB; Lagoo A; Lal S
J Rheumatol; 1998 Dec; 25(12):2364-70. PubMed ID: 9858431
[TBL] [Abstract][Full Text] [Related]
35. Lupus nephritis in autoimmune-prone NZB x NZW F1 mice and mechanisms of transition of the glomerular lesions.
Tokado H; Yumura W; Shiota J; Hirose S; Sato H; Shirai T
Acta Pathol Jpn; 1991 Jan; 41(1):1-11. PubMed ID: 2031455
[TBL] [Abstract][Full Text] [Related]
36. Nephritogenicity of anti-proteoglycan antibodies in experimental murine lupus nephritis.
Kashihara N; Makino H; Szekanecz Z; Waltenbaugh CR; Kanwar YS
Lab Invest; 1992 Dec; 67(6):752-60. PubMed ID: 1460866
[TBL] [Abstract][Full Text] [Related]
37. Effect of an exogenous trigger on the pathogenesis of lupus in (NZB x NZW)F1 mice.
Yoshida H; Satoh M; Behney KM; Lee CG; Richards HB; Shaheen VM; Yang JQ; Singh RR; Reeves WH
Arthritis Rheum; 2002 Aug; 46(8):2235-44. PubMed ID: 12209530
[TBL] [Abstract][Full Text] [Related]
38. Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation of kidney function.
Kalled SL; Cutler AH; Datta SK; Thomas DW
J Immunol; 1998 Mar; 160(5):2158-65. PubMed ID: 9498753
[TBL] [Abstract][Full Text] [Related]
39. Animal models utilized in the research of autoimmune disease control: experimental therapy of glomerulonephritis in NZB/W F1 mice.
Okudaira H; Terada E; Okudaira K
Prog Clin Biol Res; 1987; 229():157-74. PubMed ID: 3601985
[TBL] [Abstract][Full Text] [Related]
40. Histopathology of lupus-like nephritis in Dnase1-deficient mice in comparison to NZB/W F1 mice.
Jacob M; Napirei M; Ricken A; Dixkens C; Mannherz HG
Lupus; 2002; 11(8):514-27. PubMed ID: 12220106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]